No edit summary |
m (1 revision imported) |
||
(No difference)
| |||
Latest revision as of 02:47, 8 May 2024
 | |
 | |
| Industry | Healthcare |
|---|---|
| Sub-Brands | Rexall • Health Mart • Uniprix |
| Products | Pharmaceuticals • Medical technology • Health care services |
 | |
| Formerly |
|
|---|---|
| Company type | Public |
| Industry | Healthcare |
| Founded | New York City, U.S. 1833 |
| Founders |
|
| Headquarters | , U.S. |
Key people | Brian S. Tyler (CEO) |
| Products | |
| Revenue |  US$308.9 billion (2024) |
 US$3.909 billion (2024) | |
| US$3.002 billion (2024) | |
| Total assets | US$67.44 billion (2024) |
| Total equity | US$−1.97 billion (2024) |
Number of employees | c. 51,000 (2024) |
| Subsidiaries | |
| Website | McKesson.com |
| Footnotes / references Financials as of March 31, 2024[update].[1] | |
McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 51,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a member of the S&P 500 and New York Stock Exchange, where it is traded under the ticker symbol NYSE: MCK.
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags.[2] The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.[3]
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the United States of America Government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses across the United States.[4][5]
- ^ "FY 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. May 8, 2024. pp. 9, 60, 62.
- ^ Mitchell, Luke (February 1, 2009). "Sick in the Head". Harper's Magazine. Archived from the original on May 25, 2017. Retrieved April 24, 2017.
- ^ Leggate, James (July 22, 2020). "What is McKesson?". FOXBusiness. Retrieved May 6, 2021.
- ^ Terry, Mark. "Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution". BioSpace. Retrieved 10 December 2021.
- ^ "McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS" (PDF). McKesson Investor Relations. Retrieved May 5, 2021.
Reports